文献速递冠心病血脂与心血管预防

脂蛋白(a)与冠心病长期斑块进展、低密度斑块及冠状动脉周围炎症的关联

Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation.
PubMed 文献 · JAMA Cardiol · 2024-01-01

该单中心前瞻性队列研究纳入267例疑似冠心病患者,间隔约10年重复行冠状动脉CT血管造影,发现脂蛋白(a)水平每翻倍,10年内斑块体积百分比额外增加0.32%,且与低密度斑块及冠状动脉周围脂肪组织炎症相关。

要点

  • 脂蛋白(a)≥125 nmol/L者斑块体积百分比为6.9%,显著高于<125 nmol/L者的3.0%。
  • 脂蛋白(a)每翻倍,10年随访期间斑块体积百分比额外增加0.32%(95%CI 0.04-0.60)。
  • 脂蛋白(a)每翻倍与基线和随访时低密度斑块存在相关,OR分别为1.23和1.21。

核心结论

  • 较高脂蛋白(a)水平与冠状动脉斑块负荷进展、低密度非钙化斑块存在及冠状动脉周围脂肪组织炎症相关。

研究设计与样本

  • 单中心前瞻性队列研究,纳入267例疑似冠心病患者,中位扫描间隔10.2年,随访期间重复行冠状动脉CT血管造影。

主要发现

  • 调整其他危险因素后,脂蛋白(a)每翻倍,10年内斑块体积百分比额外增加0.32%(95%CI 0.04-0.60)。
  • 脂蛋白(a)每翻倍与基线低密度斑块存在的OR为1.23(95%CI 1.00-1.51),与随访时低密度斑块存在的OR为1.21(95%CI 1.01-1.45)。
  • 较高脂蛋白(a)水平与基线和随访时右冠状动脉及左前降支周围冠状动脉脂肪组织衰减增加相关。

临床怎么用

  • 对于疑似冠心病患者,监测脂蛋白(a)水平可能有助于识别长期斑块进展及高风险斑块形成风险较高的个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Lipoprotein(a) (Lp[a]) is a causal risk factor for cardiovascular disease; however, long-term effects on coronary atherosclerotic plaque phenotype, high-risk plaque formation, and pericoronary adipose tissue inflammation remain unknown. OBJECTIVE: To investigate the association of Lp(a) levels with long-term coronary artery plaque progression, high-risk plaque, and pericoronary adipose tissue inflammation. DESIGN, SETTING, AND PARTICIPANTS: This single-center prospective cohort study included 299 patients with suspected coronary artery disease (CAD) who underwent per-protocol repeated coronary computed tomography angiography (CCTA) imaging with an interscan interval of 10 years. Thirty-two patients were excluded because of coronary artery bypass grafting, resulting in a study population of 267 patients. Data for this study were collected from October 2008 to October 2022 and analyzed from March 2023 to March 2024. EXPOSURES: The median scan interval was 10.2 years. Lp(a) was measured at follow-up using an isoform-insensitive assay. CCTA scans were analyzed with a previously validated artificial intelligence-based algorithm (atherosclerosis imaging-quantitative computed tomography). MAIN OUTCOME AND MEASURES: The association between Lp(a) and change in percent plaque volumes was investigated in linear mixed-effects models adjusted for clinical risk factors. Secondary outcomes were presence of low-density plaque and presence of increased pericoronary adipose tissue attenuation at baseline and follow-up CCTA imaging. RESULTS: The 267 included patients had a mean age of 57.1 (SD, 7.3) years and 153 were male (57%). Patients with Lp(a) levels of 125 nmol/L or higher had twice as high percent atheroma volume (6.9% vs 3.0%; P = .01) compared with patients with Lp(a) levels less than 125 nmol/L. Adjusted for other risk factors, every doubling of Lp(a) resulted in an additional 0.32% (95% CI, 0.04-0.60) increment in percent atheroma volume during the 10 years of follow-up. Every doubling of Lp(a) resulted in an odds ratio of 1.23 (95% CI, 1.00-1.51) and 1.21 (95% CI, 1.01-1.45) for the presence of low-density plaque at baseline and follow-up, respectively. Patients with higher Lp(a) levels had increased pericoronary adipose tissue attenuation around both the right coronary artery and left anterior descending at baseline and follow-up. CONCLUSIONS AND RELEVANCE: In this long-term prospective serial CCTA imaging study, higher Lp(a) levels were associated with increased progression of coronary plaque burden and increased presence of low-density noncalcified plaque and pericoronary adipose tissue inflammation. These data suggest an impact of elevated Lp(a) levels on coronary atherogenesis of high-risk, inflammatory, rupture-prone plaques over the long term.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Nurmohamed NS, Gaillard EL, Malkasian S, et al. Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation. JAMA Cardiol. 2024. PMID: 39018040. doi:10.1001/jamacardio.2024.1874

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。